Dexrazoxane Intravenous and Emtricitabine, rilpivirine, and tenofovir
Determining the interaction of Dexrazoxane Intravenous and Emtricitabine, rilpivirine, and tenofovir and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexrazoxane
Brand name: Totect, Zinecard
Synonyms: Dexrazoxane
Generic Name: emtricitabine / rilpivirine / tenofovir
Brand name: Complera, Odefsey
Synonyms: Emtricitabine, Rilpivirine, and Tenofovir Disoproxil Fumarate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexrazoxane Intravenous-Emtricitabine, Rilpivirine, and Tenofovir Alafenamide
- Dexrazoxane Intravenous-Emtricitabine, Rilpivirine, and Tenofovir Disoproxil Fumarate
- Dexrazoxane Intravenous-Emtriva
- Dexrazoxane Intravenous-Emtriva (Emtricitabine Capsules)
- Dexrazoxane Intravenous-Emtriva (Emtricitabine Solution)
- Dexrazoxane Intravenous-Emverm
- Emtricitabine, rilpivirine, and tenofovir-Dextenza Insert
- Emtricitabine, rilpivirine, and tenofovir-Dextenza intraocular
- Emtricitabine, rilpivirine, and tenofovir-Dextran 40
- Emtricitabine, rilpivirine, and tenofovir-Dextran 70 6% in 5% Dextrose high molecular weight
- Emtricitabine, rilpivirine, and tenofovir-Dextran 75
- Emtricitabine, rilpivirine, and tenofovir-Dextran high molecular weight